[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels

Submitted by admin on November 13, 2024 - 9:44pm
Source: 
GAO,gov
News Tags: 
GAO
regulatory
foreign drug inspections
FDA
Headline: 
[podcast]FDA's Foreign Inspections of Drug Manufacturers Have Not Rebounded to Pre-Pandemic Levels
snippet: 

FDA paused many of its in-person inspection efforts during COVID-19 because of travel disruptions and safety concerns. So now that COVID is over, are inspections back to normal? 

Do Not Allow Advertisers to Use My Personal information